EUVIMED · CrossrefZeitschrift
Gastrointestinal Cancer: Targets and Therapy
ISSN 1179-9919 · Informa UK Limited
Neueste Artikel
Gastric neuroendocrine tumors: management and challenges
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence
Models of intrahepatic cholangiocarcinoma: novel tools and therapeutic applications
Emerging treatment options for BRAF-mutant colorectal cancer
Current perspectives on hyperthermic intraperitoneal chemotherapy in gastric cancer
Evidence for improvements to risk stratification in high-risk gastrointestinal stromal tumor patients
Efficacy of trastuzumab beyond progression as second-line chemotherapy for HER2-positive advanced gastric cancer
Hereditary diffuse gastric cancer: genetics, prophylactic total gastrectomy, and follow up
Trends in incidence of gallbladder cancer – Indian scenario
Synchronous cecal adenocarcinoma and multiple colonic in situ carcinomas in hamartomatous polyps in a case of isolated Peutz–Jeghers syndrome
The role of argon plasma coagulation in the management of Barrett's esophagus: a single-center experience
Role of sunitinib for the management of pancreatic neuroendocrine tumors
The diagnostic and prognostic role of cytokines in colon cancer
The role of S-1 in the treatment of gastric cancer
Targeting HER-2 in gastric cancer – incorporation of trastuzumab into the treatment of operable disease
New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team
Precursors to invasive pancreatic cancer
Treatment of squamous cell and adenocarcinoma of the esophagus
Neoplastic lesions of endocrine cells in the gastrointestinal tract: ten evolving principles as a basis for clinical understanding
Critical appraisal of the role of everolimus in advanced neuroendocrine tumors of pancreatic origin
Anal cancer: current and future treatment strategies
A new method of endoscopic ultrasonography for determining lesion depth in early gastric cancer
Application of miRNA expression analysis on exfoliated colonocytes for diagnosis of colorectal cancer
Pathology, genetic alterations, and targets of differentially expressed microRNAs in pancreatic cancer
Emerging treatments for advanced pancreatic cancer: clinical potential of albumin-bound paclitaxel
Ramucirumab: hitting another target in gastric cancer
Emerging role of microRNAs in the treatment of hepatocellular carcinoma
Targeting cancer stem cells in hepatocellular carcinoma
Critical analysis of the potential for therapeutic targeting of mammalian target of rapamycin (mTOR) in gastric cancer
WNT/β-catenin pathway activation in hepatocellular carcinoma: a clinical perspective
EUVIMED